3-D Visualization of the Anti-Obstructive Effect of Levocetirizine

NCT01000792 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: Levocetirizine
DRUG: Levocetirizine

Sponsor

Clinical Research International Limited